Phthalic acid esters may be used as plasticizers in food-packaging materials that have direct contact with food. Under normal conditions of use small amounts of the plasticizers would be expected to migrate into the food. The safe use of the phthalic acid esters under these conditions is based on available toxicity data, as well as regulations which, in general, specify the maximum extractable fraction of plasticizer that may enter food.
Before the enactment of the Food Additives Amendment to the Federal Food, Drug and Cosmetic Act in 1958, sanctions were granted for the use of five phthalates in food-packaging material (diethyl phthalate, butylphthalyl butyl glycolate, ethylphthalyl ethyl glycolate, diisooctyl phthalate, and di-2-ethylhexyl phthalate), with the limitations that they be used in accordance with good manufacturing practice for food packaging materials, and that di-2-ethylhexyl phthalate and diisooctyl phthalate be used with foods of high water content. Foods of high water content were defined as those from which no fat would be extractedwhen the food was pressed against filter paper; under the conditions of this test, if a water spot was formed the food was considered aqueous and if a fat spot was formed the food was considered fatty. The The regulated uses of phthalates may be classified into three categories that reflect the possible levels of direct migration to foods; namely, significant, slight, and essentially zero. Table 1 lists regulated uses that could result in migration of phthalates to foods. The uses listed in Table 1 include (a) those that will be major contributors of phthalate migration to foods (includes prior sanction), and (b) those that will result in slight migration to foods. Regulated uses that, under normal conditions, would not be expected to result in migration to foods are listed in Table 2 .
Phthalate esters that are regulated for uses that would be expected to result in migration to foods are listed in Table 3 . Each ester may have several uses, some of which would result in migration to foods and others which would not. Some phthalate esters are regulated only for uses that would not be expected to result in migration to foods under normal conditions of use (Table  4 ), e.g., adhesives. The use of adhesives is based on the requirement of a functional barrier between the adhesives and the food to prevent any migration of the adhesive.
The extent of toxicological studies required to establish the safety of authorized use of phthalate esters will depend on the level of migration to food. In the case of packaging materials, which includes a restriction that the quantity of the substance used shall be reduced to the least amount reasonably possible. In addition, if all the phthalate esters were leached out of the plastic packaging material it would no longer be functional. Since levels of migration of these phthalate esters to food might be high, (2) . On this basis, the level of phthalates possibly present in the total diet will be reduced. In addition to concem for the type of food which may contain phthalate residues as a result of the migration from packaging, it is important to consider the section of the population that may be exposed to the phthalate esters. For example, CFR 121.2562(h) states that rubber articles intended for repeated use specifically exclude rubber nursing bottle nipples.
Toxicity data relating to the phthalic acid esters used in food packaging include: (a) acute oral LD50 (Table 5) ; (b) subacute toxicity studies in one or more species of laboratory animals for 13 phthalate esters; and (c) chronic toxicity studies for seven of the phthalate esters. A summary of the available data is presented in Table 6 . Some special studies, including metabolism, teratogenicity, and chick embryo studies, have been reported for a number of phthalate esters. Reproduction studies have been carried out with some phthalate esters. Toxicity data from studies with dibutyl phthalate, diisodecyl phthalate, di-2-ethylhexyl phthalate, and ethylphthalyl ethyl glycolate, will be presented in detail to provide information on the most widely used plasticizers and to present a reasonable toxicity profile for the presently regulated phthalates.
Dibutyl Phthalate
The acute oral LD 50 in the rat is 8-16 g/kg. When rats were dosed twice weekly with dibutyl phthalate (1 ml/kg of body weight of a solution in oil) for a period of 6 (4) 100 (14) 150 (13) 75 (13) 1000 (13) 500 (13) 27 (104) 14 (52) 240 (4) 500 (17 200(13) 500(4) 500 (13) 750 (104) 250 (104) 450 (104) 500 (13) 250 (13) 65 (104) 250 (52) (8), (8), (8) FDA 60(52) (9) , (10), (11), (11) 
partially dose-related increase in resorption (4-37%) (9) (10) (11) . In general, chronic feeding studies with rats have indicated a no-effect level of 60 mg/kg of body weight/day. At higher dose levels (200-400 mg/kg/day), depressed growth rates as well as enlarged liver and kidneys were reported. In a study with guinea pigs maintained for 1 yr on a diet containing 0.04-0.13% of DEHP, the only effect notedc was increased liver weight in females. Since the effect was not dose-related and no histopathological lesions were observed, the significance of this effect is not known.
When dogs were fed 0.03 ml/kg of body weight/day of DEHP 5 days a week for a total of 29 doses and then 0.06 ml/kg/day for a total of 240 doses or 77 doses of 0.06 ml/kg day followed by 169 doses at 0.09 ml/kg/day, satisfactory weight gain was observed. Hematologic and biochemical tests, including liver function tests, were normal. The dog maintained on the high dose level showed some histological changes in the liver and kidney. These were reported as congestion in the subcapsular area of the liver and moderate congestion of the kidney with cloudy swelling.
Limited reproduction studies with rats maintained on dietary DEHP at levels of 0.04, 0.13, or 0.4% have been reported (10) . The rats were bred, and the F1 offspring were maintained on the test diet for 1 yr.
Comparison of reproductive performance (litters born, total numbers of pups born, mean size of litters, maximum numbers of litters by any female, pups stillborn) showed that the only valid change in the test animals was a decrease in the mean number of litters per female among the F1 rats at 0.4% dietary level. Both the parental and first filial generations maintained in the 0.4% dietary group showed increased liver and kidney weights. However, no significant histopathologic effects were observed.
Teratogenic studies (13) showed that although IP administration of DEHP to female rats caused some resorption of fetuses, no teratogenicity was observed. In a previous study, McLaughlin et al. (16) reported that the undiluted ester did not have any effect on the development of the chick embryo. Limited metabolic studies have also been reported in the dog, rabbit, and man (9) . Dogs dosed with DEHP at approximately 0.2 g/kg of body weight excreted phthalate equivalent to 2.0-4.5% of the dose in the urine in a 72-hr period subsequent to dosing. In a study with rabbits dosed with DEHP at approximately 1-0.6 g/kg of body weight, 26-65.4% of the administered dose was excreted in the urine. No increase in urinary excretion of glycuronic acid, ethereal sulfate, or conjugated amino acids was observed in rabbits and rats in these studies, although a large increase in the urinary excretion of fatty acids was observed. The significance of the increased urinary fatty acids is not known. Humans administered 5 or 10 g of DEHP excreted approximately 4.5% of the dose in urine in a 24-hr period after dosing. Most was excreted between 5 and 7 hr after the dosing.
o-Phthalic acid is excreted unchanged in dogs, rabbits, and humans. Since the compound is almost quantitatively excreted in the urine following oral administration (17) , it has been considered likely that the phthalate content of the urine is a measure of the intestinal absorption of the phthalate ester. Hydrolysis of DEHP may not occur in the liver. When isolated rat livers were perfused with solutions containing DEHP, the DEHP was not metabolized but accumulated in that organ, primarily in the unmetabolized form (18) .
Ethylphthalyl Ethyl Glycolate (EPEG)
In studies reported by Hodge et al. (8) , rats were maintained on diets containing 0, 0.05, 0.5, or 5.0% EPEG for 2 yr. Rats in the group given 5% showed retardation in growth and longevity, with none of the males surviving the 55th week of feeding and none of the females surviving the 72nd week. Hematological data were normal with the exception of a slight anemia in the group given 5% EPEG. Urine analyses were normal in the groups given 0.05 or 0.5%. Elevated sugar levels were observed only in the group given 5%, and histopathological studies indicated marked changes in the kidneys of these rats. The changes consisted of crystalline masses of calcium oxalate in the renal tubules, and the origin of these crystals was attributed to the ethyl glycolate moiety. Dogs In general, good metabolic data on the phthalate esters are lacking. It would be highly desirable to carry out studies to determine the extent of absorption and subsequent metabolism in a species that is known to metabolize the phthalate moiety in a manner similar to man. Although it has previously been assumed that the phthalate esters would be hydrolyzed to free phthalic acid and the alcohol in the gut and the products of digestion absorbed, the more recent information suggests that some phthalate may be absorbed unchanged and that metabolism in the rat may not proceed greatly beyond the monoester stage (14) . The structure of the phthalate ester may be an important factor in determining the site and rate of metabolism, since butyl glycolylbutyl phthalate was metabolized by isolated perfused rat liver, whereas DEHP accumulated in the liver unchanged (18 The significance of the teratogenic effects following IP administration of large doses of phthalate cannot be assessed in terms of the normal dietary exposure. For safety evalua-tions of substances that may enter the diet, emphasis must be placed on the results of oral toxicity studies, and there is a need to carry out studies with phthalates given orally at levels related to their possible daily intake.
In summary, the available information indicates that the levels of phthalates occurring in the diet from authorized uses do not pose any toxicological hazard. It is recognized that this statement is based in part on the premise that phthalates as a class are metabolized in a similar manner, thus allowing a general approach to the toxicity of these compounds.
